Understanding how this medication works and what the research shows can help patients make informed decisions about their treatment
I have patients who cannot tolerate Wegovy (semaglutide) but can tolerate Zepbound (tirzepatide), or, alternatively, they tolerate Wegovy but not Zepbound," she says
Average weight loss depends on the dose, treatment length, and whether the patient also has type 2 diabetes
[9] For instance, someone taking insulin or oral hypoglycemics might experience sudden drops in blood sugar if NAD enhances glucose uptake
Medical conditions that interfere Sometimes the biggest barrier to weight loss isnt Semaglutide
In people, obesity is associated with lower physical activity, but mice don't tend to become less active when they gain weight